Cargando…

Roles of Altered Macrophages and Cytokines: Implications for Pathological Mechanisms of Postmenopausal Osteoporosis, Rheumatoid Arthritis, and Alzheimer’s Disease

Postmenopausal osteoporosis (PMOP) is characterized by the uncoupling of bone resorption and bone formation induced by estrogen deficiency, which is a complex outcome related to estrogen and the immune system. The interaction between bone and immune cells is regarded as the context of PMOP. Macropha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yunteng, Yan, Hui, Zhang, Xin, Zhuo, Junkuan, Han, Yidan, Zhang, Haifeng, Xie, Dingbang, Lan, Xin, Cai, Wanping, Wang, Xiaoning, Wang, Shanshan, Li, Xihai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226340/ https://www.ncbi.nlm.nih.gov/pubmed/35757427 http://dx.doi.org/10.3389/fendo.2022.876269

Ejemplares similares

Role of the major histocompatibility complex class II protein presentation pathway in bone immunity imbalance in postmenopausal osteoporosis
por: Wang, Xiaoning, et al.
Publicado: (2022)

Icariin promotes osteogenic differentiation by upregulating alpha-enolase expression
por: Xie, Dingbang, et al.
Publicado: (2023)

Effects of Icariin on Modulating Gut Microbiota and Regulating Metabolite Alterations to Prevent Bone Loss in Ovariectomized Rat Model
por: Wang, Shanshan, et al.
Publicado: (2022)

MicroRNAs in Serum Exosomes as Circulating Biomarkers for Postmenopausal Osteoporosis
por: Shi, Hongli, et al.
Publicado: (2022)

Discovery of Potential Biomarkers for Postmenopausal Osteoporosis Based on Untargeted GC/LC-MS
por: Kou, Jun, et al.
Publicado: (2022)

Identification of ferroptosis-associated biomarkers for the potential diagnosis and treatment of postmenopausal osteoporosis
por: Hu, Yunxiang, et al.
Publicado: (2022)

Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis
por: Suzuki, Takako, et al.
Publicado: (2017)

Analysis and Validation of Hub Genes in Blood Monocytes of Postmenopausal Osteoporosis Patients
por: Deng, Yi-Xuan, et al.
Publicado: (2022)

The relationship between the monocyte-to-lymphocyte ratio and osteoporosis in postmenopausal females with T2DM: A retrospective study in Chinese population
por: Li, Hailin, et al.
Publicado: (2023)

The utility of clinical decision tools for diagnosing osteoporosis in postmenopausal women with rheumatoid arthritis
por: Brand, Caroline, et al.
Publicado: (2008)

Significance of pyroptosis-related gene in the diagnosis and classification of rheumatoid arthritis
por: Li, Jian, et al.
Publicado: (2023)

Does the VDR gene polymorphism influence the efficacy of denosumab therapy in postmenopausal osteoporosis?
por: Wawrzyniak, Anna, et al.
Publicado: (2023)

Bone Microarchitecture in Obese Postmenopausal Chinese Women: The Chinese Vertebral Osteoporosis Study (ChiVOS)
por: Qi, Wenting, et al.
Publicado: (2022)

Disturbed bone marrow adiposity in patients with Cushing’s syndrome and glucocorticoid- and postmenopausal- induced osteoporosis
por: Sørensen, Nina N., et al.
Publicado: (2023)

The Imbalance of Cytokines and Lower Levels of Tregs in Elderly Male Primary Osteoporosis
por: Zhang, Wei, et al.
Publicado: (2022)

Risk of infection in postmenopausal women with rheumatoid arthritis and osteoporosis taking denosumab and bDMARDS
por: Mirzaei, Alireza, et al.
Publicado: (2021)

Increased Risk of Thyroid Dysfunction Among Patients With Rheumatoid Arthritis
por: Li, Qian, et al.
Publicado: (2019)

Association of Vitamin D Receptor Gene Variation With Osteoporosis Risk in Belarusian and Lithuanian Postmenopausal Women
por: Marozik, Pavel M., et al.
Publicado: (2018)

Effectiveness of Yushen Hezhi therapy for postmenopausal osteoporosis: An overview of systematic reviews of randomized controlled trials
por: Zhao, Jinlong, et al.
Publicado: (2022)

Additive Effects of VDBP and 1,25(OH)2D3 on the Viability and Apoptosis of Rheumatoid Arthritis Synovial Fibroblasts
por: Zhang, Yeyong, et al.
Publicado: (2021)

Complement receptor C5aR1 on osteoblasts regulates osteoclastogenesis in experimental postmenopausal osteoporosis
por: Bülow, Jasmin Maria, et al.
Publicado: (2022)

Profile of Abaloparatide and Its Potential in the Treatment of Postmenopausal Osteoporosis
por: Tella, Sri Harsha, et al.
Publicado: (2017)

Impact of Osteoporosis in Postmenopausal Women With Primary Knee Osteoarthritis
por: Zamzam, Mohammed, et al.
Publicado: (2023)

High Follicle-Stimulating Hormone Level Associated With Risk of Rheumatoid Arthritis and Disease Activity
por: Zhang, Xianhui, et al.
Publicado: (2022)

Bioinformatics identification and experimental validation of m6A-related diagnostic biomarkers in the subtype classification of blood monocytes from postmenopausal osteoporosis patients
por: Zhang, Peng, et al.
Publicado: (2023)

Comparative Efficacy of Xianling Gubao Capsules in Improving Bone Mineral Density in Postmenopausal Osteoporosis: A Network Meta-Analysis
por: Luo, Ming-hui, et al.
Publicado: (2022)

Genetically predicted C-reactive protein mediates the association between rheumatoid arthritis and atlantoaxial subluxation
por: Yuan, Jiaqin, et al.
Publicado: (2022)

Corrigendum: High follicle-stimulating hormone level associated with risk of rheumatoid arthritis and disease activity
por: Zhang, Xianhui, et al.
Publicado: (2023)

Corrigendum: Genetically predicted C-reactive protein mediates the association between rheumatoid arthritis and atlantoaxial subluxation
por: Yuan, Jiaqin, et al.
Publicado: (2023)

Rheumatoid arthritis increases the risk of heart failure-current evidence from genome-wide association studies
por: Wang, Min, et al.
Publicado: (2023)

New insights into the impact of neuro-inflammation in rheumatoid arthritis
por: Fuggle, Nicholas R., et al.
Publicado: (2014)

Gut bacteriome, mycobiome and virome alterations in rheumatoid arthritis
por: Dagar, Sonali, et al.
Publicado: (2023)

Higher serum uric acid levels are associated with reduced risk of hip osteoporosis in postmenopausal women with rheumatoid arthritis
por: Lee, Han-Na, et al.
Publicado: (2020)

Identification and validation of ferroptosis key genes in bone mesenchymal stromal cells of primary osteoporosis based on bioinformatics analysis
por: Xia, Yu, et al.
Publicado: (2022)

Low BMI, blood calcium and vitamin D, kyphosis time, and outdoor activity time are independent risk factors for osteoporosis in postmenopausal women
por: Tang, Guo, et al.
Publicado: (2023)

Mapping theme trends and recognizing hot spots in postmenopausal osteoporosis research: a bibliometric analysis
por: Zhou, Siming, et al.
Publicado: (2019)

Osteoporosis diagnostics in patients with rheumatoid arthritis
por: Węgierska, Małgorzata, et al.
Publicado: (2016)

Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons
por: Llorente, Irene, et al.
Publicado: (2020)

Mechanisms of Systemic Osteoporosis in Rheumatoid Arthritis
por: Pietschmann, Peter, et al.
Publicado: (2022)

Multiple doses of SHR-1222, a sclerostin monoclonal antibody, in postmenopausal women with osteoporosis: A randomized, double-blind, placebo-controlled, dose-escalation phase 1 trial
por: Dai, Zhijie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h1qevpqapc5ajsm08pf3rfdg7u